Subjects, methods, and results
Full details of the methods have been reported elsewhere. 5 Records from 15 practices in London (121 608 patients) were screened for a diagnosis of Parkinson's disease or parkinsonism; antiparkinsonian drugs; or mention of tremor after the age of 50 years. Diagnosis was based on clinical assessment (by AS), with a video recording for secondary confirmation (by NPQ). Idiopathic Parkinson's disease was diagnosed according to the criteria of the UK Parkinson's Disease Society Brain Bank, w1 with the exception that an isolated positive Babinski sign in an elderly patient with otherwise typical idiopathic Parkinson's disease was not considered to invalidate the diagnosis. Isolated classic resting tremor was considered to be "possible" Parkinson's disease. Multiple system atrophy and progressive supranuclear palsy were diagnosed according to published criteria. w2 w3 Vascular parkinsonism was diagnosed if at least two of the following were present: history of strokes, abrupt onset with stepwise progression, hypertension, a wide based gait with small steps, cognitive decline, pseudobulbar or pyramidal signs. Drug induced parkinsonism was diagnosed if a dopamine receptor blocking drug had been started within six months of the onset of symptoms and taken for at least six months. The date taken for calculating prevalence was 1 July 1997. We calculated crude prevalence rates and age adjusted rates by direct standardisation to the 1997 UK population, and a 95% confidence interval was calculated with Smith's method.
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Initial screening identified 679 patients, of whom 438 were excluded because they had drug induced parkinsonism, presented with dementia, or had no evidence of parkinsonism. Of the remaining 241 patients, 33 declined to participate and 6 died before they could be seen (response rate 84% ous diagnosis of parkinsonism is of some concern and deserves further attention.
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Subjects, methods, and results
We identified a random sample of 100 patients a year from 1988 to 1997 from the database of cardiothoracic surgery in our regional centre. We sent postal questionnaires to their general practitioners about current aspirin treatment, smoking status, blood pressure, and cholesterol concentration and treatment and compared responses with local audit standards. We received completed questionnaires from 94 practices about 761 (76%) patients, of whom 563 were alive. Aspirin was prescribed to 451 (80%) patients, and 65 (12%) continued to smoke. Seventy patients (12%) had systolic pressure greater than 160 mm Hg and 43 (8%) had diastolic pressure greater than 90 mm Hg. These risk factors did not vary by year of operation.
The proportion of patients with cholesterol measured and below the audit standard ( < 5.2 mmol/l) rose from 12% (5/42) for those operated on in 1988 to 50% (37/72) for those operated on in 1997. The proportion of patients with correctly managed cholesterol significantly increased for those operated on after publication of the Scandinavian simvastatin survival study in 1994 (figure, P < 0.0001).
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Two hundred and seventy patients (48%) attended practices that had audited their management of secondary prevention, but the proportion of patients managed appropriately was virtually identical in audited and non-audited practices (37% (99/270) v 34% (99/291), P = 0.956).
Comment
Our audit has shown that the standard of secondary preventative care was good for well established risk factors 3 but less good for management of cholesterol. Although there has been considerable improvement over the past decade, 48% of patients were still not managed optimally in 1997. Patients who had bypass surgery before the 1994 study 4 were less likely to receive cholesterol lowering treatment, probably because they had been discharged from specialist review and were less likely to consult their general practitioner.
The proportion of patients with suboptimally managed cholesterol was similar in practices that had and 
